Multicenter, randomized trial comparing a combined gemcitabine and cisplatin 3-week regimen with a 4-week regimen in non-small cell lung cancer (NSCLC) patientsM. Liao, L. Wang, L. Li et al.|Journal of Clinical Oncology|2006Cited by 0